MLYS
Mineralys Therapeutics Inc.
$31.56
+$0.69(+2.24%)
37
Overall
50
Value
20
Tech
42
Quality
Market Cap
$2.60B
Volume
1.83M
52W Range
$8.24 - $47.65
Target Price
$50.88
EPS Estimates Overview
| Current Quarter | $-0.57 | Next Quarter | $-0.6 |
| Current Year | $-2.44 | Next Year | $-2.5 |
| QoQ Growth | -5.3% | YoY Growth | -2.5% |
| 3Y EPS CAGR | N/A | Target Price | $50.88 |
| Consensus | Buy | Upside | +61.2% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $31.56 | +2.2% | 1.83M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW